Clinical Trials
Eli Lilly Begins Phase III Study of RA Drug...
Eli Lilly will assess its JAK1/JAK2 inhibitor Olumiant (baricitinib) as a potential treatment for COVID-19 in a Phase III study.
Indianapolis-based Eli Lilly said the latest...
Articles
Creating your Secondary Packaging Strategy
When to Start Creating Your Secondary Packaging Strategy
Pharmaceutical and biotechnology companies with a drug product in clinical development are usually focused on a quick commercial...
Clinical Trials
Greenphire Enhances Its Participant Payment and Reimbursement Solution to...
As the COVID-19 pandemic continues to limit movement all over the world, clinical trials have had to adapt by leveraging methodologies typically associated with hybrid...
News
NSF-funded Smartphone COVID-19 Diagnostic Test Could Put Testing in...
A smartphone diagnostic test for COVID-19 being developed by a University of Utah researcher holds the potential for quick, accurate testing without the need for...
Press Releases
Sterling Pharma Solutions commence the production of potential COVID-19...
Global contract development and manufacturing organisation (CDMO), Sterling Pharma Solutions, has commenced production of hydroxychloroquine (HCQ), a treatment currently under investigation for COVID-19.
Sterling will be...
Press Releases
Abbott Earns Emergency Use Authorization for Another COVID-19 Antibody...
Abbott Laboratories has won Emergency Use Authorization for another COVID-19-related diagnostics test for antibodies. This morning, the company said the U.S. Food and Drug Administration...
Clinical Trials
Glenmark initiates Phase 3 clinical trials on antiviral Favipiravir...
Glenmark Pharmaceuticals, a research-led, integrated global pharmaceutical company has initiated Phase 3 clinical trials in India on Antiviral tablet Favipiravir, for which it received approval...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.